GMP non-compliance can spill over and impact patient access to life-saving medications.
Sharon Ayd
Advertisement
Sharon Ayd is chief scientific officer and SVP, Pharmaceuticals at Regulatory Compliance Associates.
Articles by Sharon Ayd
Creating a quality culture can prevent the costs and challenges associated with receiving a consent decree.
Advertisement
Latest Updated Articles
Managing the Cost of Non-ComplianceNovember 2nd 2017
Impact of Non-Compliance on the American Healthcare ConsumerDecember 2nd 2018
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
France Remains One of Europe’s Leading Biotech Funding Hubs
2
CPHI Pharma Award Winner: Drug Delivery, Devices, & Packaging
3
Investing in Protecting Pharma Products
4
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
5